Regenerx Biopharm In Stock Earnings Per Share
| RGRXDelisted Stock | USD 0.03 0.01 25.00% |
Regenerx Biopharm In fundamentals help investors to digest information that contributes to Regenerx Biopharm's financial success or failures. It also enables traders to predict the movement of Regenerx OTC Stock. The fundamental analysis module provides a way to measure Regenerx Biopharm's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Regenerx Biopharm otc stock.
Regenerx |
Regenerx Biopharm In OTC Stock Earnings Per Share Analysis
Regenerx Biopharm's Earnings per Share (EPS) denotes the portion of a company's earnings that is allocated to each share of common stock. To calculate Earnings per Share investors will need to take a company's net income, subtract any dividends for preferred stock, and divide it by the number of average outstanding shares. EPS is usually presented in two different ways: basic and diluted. Fully diluted Earnings per Share takes into account effects of warrants, options, and convertible securities and is generally viewed by analysts as a more accurate measure.
Current Regenerx Biopharm Earnings Per Share | (0.01) X |
Most of Regenerx Biopharm's fundamental indicators, such as Earnings Per Share, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Regenerx Biopharm In is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Earnings per Share is one of the most critical measures of the firm's current share price and is used by investors to determine the overall company profitability, especially when compared to the EPS of similar companies.
CompetitionAccording to the company disclosure, Regenerx Biopharm In has an Earnings Per Share of -0.012 times. This is 100.14% lower than that of the Biotechnology sector and 99.75% lower than that of the Health Care industry. The earnings per share for all United States stocks is 100.38% higher than that of the company.
Regenerx Earnings Per Share Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Regenerx Biopharm's direct or indirect competition against its Earnings Per Share to detect undervalued stocks with similar characteristics or determine the otc stocks which would be a good addition to a portfolio. Peer analysis of Regenerx Biopharm could also be used in its relative valuation, which is a method of valuing Regenerx Biopharm by comparing valuation metrics of similar companies.Regenerx Biopharm is currently under evaluation in earnings per share category among its peers.
Regenerx Fundamentals
| Return On Asset | -0.84 | ||||
| Operating Margin | (19.03) % | ||||
| Current Valuation | 22.91 M | ||||
| Shares Outstanding | 143.55 M | ||||
| Shares Owned By Insiders | 45.99 % | ||||
| Shares Owned By Institutions | 0.01 % | ||||
| Number Of Shares Shorted | 19.19 K | ||||
| Price To Earning | 17.73 X | ||||
| Price To Sales | 261.81 X | ||||
| Revenue | 76.76 K | ||||
| Gross Profit | 70.12 K | ||||
| EBITDA | (1.27 M) | ||||
| Net Income | (1.6 M) | ||||
| Cash And Equivalents | 478.41 K | ||||
| Total Debt | 1.14 M | ||||
| Current Ratio | 1.05 X | ||||
| Book Value Per Share | (0.02) X | ||||
| Cash Flow From Operations | (990.3 K) | ||||
| Short Ratio | 0.15 X | ||||
| Earnings Per Share | (0.01) X | ||||
| Target Price | 1.5 | ||||
| Beta | 0.54 | ||||
| Market Capitalization | 20.1 M | ||||
| Total Asset | 1.28 M | ||||
| Retained Earnings | (105.27 M) | ||||
| Working Capital | 806 K | ||||
| Current Asset | 1.19 M | ||||
| Current Liabilities | 382 K | ||||
| Net Asset | 1.28 M |
About Regenerx Biopharm Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Regenerx Biopharm In's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Regenerx Biopharm using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Regenerx Biopharm In based on its fundamental data. In general, a quantitative approach, as applied to this otc stock, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any otc stock could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area. You can also try the Equity Forecasting module to use basic forecasting models to generate price predictions and determine price momentum.
Other Consideration for investing in Regenerx OTC Stock
If you are still planning to invest in Regenerx Biopharm check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Regenerx Biopharm's history and understand the potential risks before investing.
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
| CEOs Directory Screen CEOs from public companies around the world | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing |